COSCIENS Biopharma Inc. (LON:0UGB)
London · Delayed Price · Currency is GBP · Price in CAD 3.410
-0.790 (-18.81%)
At close: Nov 6, 2025
COSCIENS Biopharma Market Cap
COSCIENS Biopharma has a market cap or net worth of 4.94 million as of December 19, 2025. Its market cap has decreased by -44.79% in one year.
Market Cap
4.94M
Enterprise Value
137.99K
Revenue
6.74M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.41
Market Cap Chart
Since April 22, 1996, COSCIENS Biopharma's market cap has decreased from 7.20B to 4.94M, a decrease of -99.93%. That is a compound annual growth rate of -21.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 4.94M | 28.58% |
| Dec 31, 2024 | 3.84M | -48.21% |
| Dec 29, 2023 | 7.42M | -42.06% |
| Dec 30, 2022 | 12.80M | -60.28% |
| Dec 31, 2021 | 32.23M | 65.68% |
| Dec 31, 2020 | 19.46M | 40.20% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 210.09B |
| HSBC Holdings | 197.25B |
| Shell | 152.57B |
| Unilever | 108.28B |
| Rio Tinto Group | 98.82B |
| Rolls-Royce Holdings | 95.76B |
| British American Tobacco p.l.c. | 93.12B |
| GSK plc | 72.73B |